$WAY

Waystar Non-GAAP EPS of $0.44 beats by $0.03, revenue of $325.6M beats by $2.19M (NASDAQ:WAY)

Waystar Holding Corp. (WAY) reported Q3 Non-GAAP EPS of $0.44, beating estimates by $0.03. Revenue was $325.6M, up 21.2% year-over-year and exceeding expectations by $2.19M. The company also provided full-year 2026 revenue guidance.

Original reporting
Published Nov 2, 2026, 9:58 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 2, 2026, 10:01 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$WAY
Bullish
medium confidence
Mentioned
$WAY
Relevance
9/10
AlphAI data visualization · based on seekingalpha.com
Decision brief

The 30-second read

$WAYBullishMed
01

Why it matters

A reported EPS and revenue beat usually improves near-term positioning, but the magnitude and direction of the reaction depends on how the FY2026 guidance compares with Street expectations and prior guidance.

02

Market read

This is a company-specific earnings and guidance disclosure that can drive same-day repricing and near-term expectation resets for WAY.

03

What to watch

Traders will likely focus on the full-year guidance specifics, margin trajectory, and any commentary on customer growth or churn, which are not included in the provided excerpt.

Relevance 9/10Novelty 8/10Timing: after-hours, Nov 2, 2026 earnings release

Background

The piece is an earnings update for Waystar’s Q3 results, citing the company’s press release and noting full-year 2026 guidance is provided.

Company-level read

Ticker impact

$WAYBullishMedium confidence
Context

Waystar reported Q3 non-GAAP EPS of $0.44 and revenue of $325.6M, both beating by stated margins, plus full-year 2026 guidance.

Expected impact

Likely upward pressure as traders price in stronger-than-expected Q3 performance and assess the implied FY2026 trajectory from the new guidance.

Evidence & confidence

The article discloses a fresh quarterly earnings print with explicit beat figures and indicates the company issued updated full-year guidance, which typically drives immediate repricing versus prior expectations.

Market effects

Signals demand and pricing momentum for the healthcare/benefits administration software and services cohort, potentially supporting peer sentiment.

Primarily US-listed single-name impact; limited spillover beyond healthcare services software investors.

Low global relevance; this is a company-specific earnings and guidance update.

Counterpoint

If the omitted guidance details (not shown in the scrape) are weaker than expected, the stock could fade despite the headline EPS and revenue beats.

Key entities

  • Waystar Holding Corp.

    Subject of the article, reporting Q3 non-GAAP EPS and revenue beats and providing FY2026 guidance.

Related articles

$WAYHighAI 8/10

Waystar Holding Corp (WAY) Q3 2026 Earnings Call Highlights: Revenue Jumps 21% as AI Bookings Surge

Waystar Holding Corp (WAY) reported Q3 2026 revenue growth of 21% YoY, with adjusted EBITDA up 24% and a 43% margin. Bookings surged 25% YoY, including a major client win. AI innovations drove 43% of Q3 bookings. However, Q4 revenue growth is expected to slow to ~6%, with adjusted EBITDA declining sequentially due to top-line variability and AI investments. Iodine's performance-based pricing model delayed revenue recognition. Net revenue retention was 108%, at the lower end of historical range.

$WAYMed

Waystar: Q3 Earnings Snapshot

Waystar Holding Corp. (WAY) reported Q3 earnings of $31M, or 16 cents per share, beating estimates. Adjusted EPS was 44 cents. Revenue was $325.6M, also exceeding forecasts. The company expects full-year EPS of $1.63-$1.71 and revenue of $1.28B-$1.29B.

$WAYHighAI 8/10

What Waystar (WAY) Said on Its Q3 Earnings Call

Waystar (WAY) reported Q3 bookings for Iodine exceeded year-to-date plans by 74%, with $15M in Q3 bookings. The company launched an autonomous claim-resubmission feature, estimating it could resubmit up to $5B in rejected claims annually. Waystar lowered its full-year revenue forecast to $1.277B-$1.287B but raised adjusted EBITDA guidance to $543M-$549M. The company cited timing pressures for the revenue outlook adjustment.

$WAYHighAI 8/10

Waystar shares tumble 7% on weak fiscal 2026 guidance

Waystar Holding Corp (WAY) reported Q3 earnings of $0.44 per share, beating estimates, with revenue up 21% YoY to $325.6M. However, shares fell 7.3% on weak fiscal 2026 guidance, with projected EPS of $1.63-$1.71 and revenue of $1.277B-$1.287B, both below consensus. The company reported 10% net income margin and 43% adjusted EBITDA margin.